riTUXimab
*Alternate biosimilar approved for ambulatory clinics when HFH preferred rituximab biosimilar (Ruxience) not covered by insurance.
*Alternate biosimilar approved for ambulatory clinics when HFH preferred rituximab biosimilar (Ruxience) not covered by insurance.